2012-07-02 TSC Call Minutes

Standing Conference Calls

TSC will hold a Conference Call at 11AM Eastern time, each Monday except during scheduled face-to-face Working Group Meetings unless otherwise noted at TSC_Minutes_and_Agendas.

GoToMeeting at https://global.gotomeeting.com/join/426505829 using VOIP

For those without access to microphone/speakers:

US: +1 (224)501-3318

Canada: +1 (647)497-9379

Italy: +39 0 230 57 81 80

Access Code: 426-505-829

GoToMeeting ID: 426-505-829

HL7 TSC Meeting Minutes Location: call 770-657-9270 using code 985371# GoToMeeting ID: 165-215-206		Date: 2012-07-02 Time: 11:00 AM U.S. Eastern
Facilitator: Austin Kreisler		Note taker(s): Lynn Laakso

Quorum = chair + 5 including 2 SD represented				yes/no
Chair/CTO		ArB		International Affiliate Rep		Ad-Hoc
.	Austin Kreisler	.	Charlie Mead	.	Ravi Natarajan	.	Helen Stevens
.	John Quinn	.	Ron Parker	.	Giorgio Cangioli
Domain Experts		Foundation and Technology		Structure and Semantic Design		Technical and Support Services
.	Ed Tripp	.	Woody Beeler	.	Calvin Beebe	.	Freida Hall
.	Mead Walker	.	Tony Julian	.	Pat van Dyke	.	Patrick Loyd
ex officio		Invited Guests		Observers		HL7 Staff
.	Don Mon (HL7 Chair) w/vote	.	tba	.	obs1	.	Lynn Laakso
.	Bob Dolin (Vice Chair) vote	.	tba	.	obs2	.
.	Chuck Jaffe (CEO) vote	.	tba	.	.	.

Agenda

Agenda Topics

1. Introduction of visitors (including declaration of interests)
2. Agenda review and approval - Austin Kreisler
3. Approve Minutes of 2012-06-18 TSC Call Agenda and 2012-06-25 TSC Call Agenda
4. Review action items –
5. Approval items:
   • Motion: Approve project scope statement for V3 Nutrition Order Clinical Messages, for OO of SSD SD, cosponsored by Pharmacy and Patient Care of DESD, at Project Insight # 902 and TSC Tracker #2298.
   • Motion: Approve project scope statement for HL7/S&I Framework QRDA II/III Draft Standard for Trial Use, Release 3, for SDWG of SSD SD, at Project Insight #896 and TSC Tracker #2299.
   • Motion: Approve project scope statement for Patient Authored Documents, for SDWG of SSD SD, at Project Insight # 900 and TSC Tracker #2300.
   • Motion: Approve project scope statement for QRDA Draft Standard for Trial Use, Release 3, for SDWG of SSD SD, at Project Insight # 210 and TSC Tracker #2301.
   • Motion: Approve project scope statement for Health Quality Measure Format (HQMF) Specification, Release 2, for SDWG of SSD SD, at Project Insight #508 and TSC Tracker #2302.
   • Motion: Approve project scope statement for QDM-based Health Quality Measure Format (HQMF) Implementation Guide , for SDWG of SSD SD cosponsored by CDS at Project Insight #756 and TSC Tracker #2303.
   • Motion: Approve project scope statement for CDA Implementation Guide for Patient Assessments, for SDWG of SSD SD, at Project Insight #381 and TSC Tracker #2304.
   • Motion: Approve project scope statement for HL7/IHE Health Story Implementation Guide Consolidation – additional templates for patient assessment data, for SDWG of SSD SD, at Project Insight #728 and TSC Tracker #2305.
   • Motion: Approve project scope statement for HL7/OHT Health Ingenuity Exchange Alpha Program Participation, for Tooling WG T3SD, cosponsored by Publishing and Templates WGs at Project Insight #904 and TSC Tracker #2306.
   • Motion: Approve project scope statement for RIM Certification Test Upgrade, for Education WG of T3SD, cosponsored by MnM at Project Insight #886 and TSC Tracker #2307.
6. Discussion topics:
   • Approval of FHIR Governance terms of reference
   • TSC scheduling of governance discussions separate from management of project approvals
   • IGs for publishing to meet MU Stage 2 deadlines
   • Strategic_Initiatives_TSC_Dashboard review of updates and suggestions - with Dave Hamill
7. Reports: (attach written reports below from Steering Divisions et al.)
8. Open Issues List

Supporting Documents

• See links

Minutes

Minutes/Conclusions Reached:

Please don't forget to hang up from the conference call (VOIP users)

Next Steps

Actions (Include Owner, Action Item, and due date) .

Next Meeting/Preliminary Agenda Items .

© 2012 Health Level Seven® International. All rights reserved.